Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2059-3635

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects ; volume:7 ; number:1 ; day:4 ; month:6 ; year:2022 ; pages:1-2 ; date:12.2022
Signal transduction and targeted therapy ; 7, Heft 1 (4.6.2022), 1-2, 12.2022

Creator: Liu, Longlong
Patnana, Pradeep Kumar
Nimmagadda, Subbaiah Chary

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41392-022-01040-9

URN: urn:nbn:de:101:1-2022080319330440568047

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liu, Longlong
Patnana, Pradeep Kumar
Nimmagadda, Subbaiah Chary
SpringerLink (Online service)

Other Objects (12)

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

AMPK contributes to autophagosome maturation and lysosomal fusion

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation

Health benefits of late-onset metformin treatment every other week in mice

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

AMPK contributes to autophagosome maturation and lysosomal fusion

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation

Health benefits of late-onset metformin treatment every other week in mice

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

AMPK contributes to autophagosome maturation and lysosomal fusion

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation

Health benefits of late-onset metformin treatment every other week in mice

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

AMPK contributes to autophagosome maturation and lysosomal fusion

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation

Health benefits of late-onset metformin treatment every other week in mice

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

AMPK contributes to autophagosome maturation and lysosomal fusion

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation

Health benefits of late-onset metformin treatment every other week in mice

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

AMPK contributes to autophagosome maturation and lysosomal fusion

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation

Health benefits of late-onset metformin treatment every other week in mice

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Related objects

Reset password